SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022136
Filing Date
2020-05-07
Accepted
2020-05-06 18:39:29
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20200331.htm   iXBRL 10-Q 2462759
2 EX-10.2 rare-ex102_357.htm EX-10.2 36574
3 EX-10.3 rare-ex103_358.htm EX-10.3 45740
4 EX-31.1 rare-ex311_6.htm EX-31.1 17447
5 EX-31.2 rare-ex312_7.htm EX-31.2 17446
6 EX-32.1 rare-ex321_8.htm EX-32.1 10868
7 GRAPHIC gzco4kx4l0j4000001.jpg GRAPHIC 50841
  Complete submission text file 0001564590-20-022136.txt   8078159

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA rare-20200331.xsd EX-101.SCH 62709
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20200331_cal.xml EX-101.CAL 50706
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20200331_def.xml EX-101.DEF 156578
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20200331_lab.xml EX-101.LAB 373965
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20200331_pre.xml EX-101.PRE 290550
32 EXTRACTED XBRL INSTANCE DOCUMENT rare-10q_20200331_htm.xml XML 1465408
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 20853997
SIC: 2834 Pharmaceutical Preparations